Valneva Confirms Delisting from the Vienna Stock Exchange

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, announces today that the Vienna Stock Exchange (“VSE”) resolved to revoke the admission of Valneva shares from the Official Market through a resolution dated September 18, 2019. Valneva’s ordinary and preferred shares will no longer trade on the VSE after December 20, 2019. They will remain tradeable on Euronext Paris (Compartment B).

  • Last VSE trading day will take place on December 20, 2019
  • Valneva shares will be automatically transferred to Euronext Paris
  • Valneva’s listing on Euronext Paris remains unchanged

Read more